Pharmacokinetics study of Tenofovir in HIV-infected adolescents in TApHOD cohort

Project no.: HIV-NAT 145/TDF PK in adolescents

The objective of this study is to describe the PK parameters of TDF when administered with PIs in HIV-infected Asian adolescent aged 12 -< 18 years.

Presentations: Pharmacokinetics of tenofovir in Thai adolescents using ritonavir-boosted protease inhibitor-based regimens. Presented as oral presentation at the 20th Conference on Retrovirus and Opportunities Infections (CROI 2013) at Atlanta, GA, USA on March 3-6, 2013.